[Form 4] Acme United Corporation Insider Trading Activity

Rhea-AI Filing Summary

Ventas, Inc. (VTR) – Form 4 insider transaction

EVP & CFO Robert F. Probst exercised 29,691 fully-vested options at an exercise price of $65.45 on 08/04/2025 (code “M”) and immediately sold the same 29,691 shares at a weighted-average price of $68.4917 (code “S”) under a Rule 10b5-1 plan adopted 19-Feb-2025. The net spread of roughly $3.04 per share implies gross proceeds of about $2.0 million before taxes.

After the transactions, Probst’s direct common-stock position is 168,364 shares and he still holds 33,591 unexercised options expiring 05/04/2026. No indirect holdings were reported. The sale represents less than 2 % of his direct ownership and is immaterial relative to Ventas’ roughly 400 million shares outstanding; no operational or earnings information is disclosed.

Insights

Securities Analyst

TL;DR: Routine 10b5-1 option exercise and sale; negligible impact on VTR valuation.

The CFO converted expiring options into shares and liquidated them for personal liquidity, reducing his direct stake by 29,691 shares. Proceeds are modest versus Ventas’ market capitalization and do not signal a strategic shift. Post-sale ownership remains substantial, mitigating negative signalling risk. The action was pre-planned, further lowering interpretive weight. I view the filing as administratively important but not valuation-relevant.

Corporate Governance Expert

TL;DR: Insiders following 10b5-1 best practices; neutral governance impact.

The transaction occurred under a disclosed 10b5-1 plan, aligning with governance guidelines and reducing concerns about information asymmetry. Frequency and scale of sales appear consistent with option-expiration cycles rather than opportunistic timing. No red flags around undisclosed pledging or derivative complexity. Overall, governance posture remains stable.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MURPHY SUSAN H

(Last) (First) (Middle)

1 WATERVIEW DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACME UNITED CORP [ ACU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/29/2025	07/29/2025	G		120	D	$42.61	7,167	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Susan H. Murphy	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Ventas (VTR) shares did CFO Robert F. Probst sell?

He sold 29,691 common shares on 08/04/2025 at a weighted-average price of $68.4917.

What was the exercise price of the options converted by the CFO?

The options were exercised at $65.45 per share.

Does the filing indicate any change in Ventas’ fundamentals or guidance?

No. The Form 4 only reports an insider’s personal trading activity; it contains no operational or earnings data.

How many Ventas shares does the CFO own after the transaction?

Following the sale, he directly owns 168,364 common shares and holds 33,591 unexercised options.

Was the sale conducted under a Rule 10b5-1 trading plan?

Yes. The filing states the sale was pursuant to a Rule 10b5-1 plan adopted on 19-Feb-2025.